You are here: Industry Insights > Diabetes

News List

Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores prnasia
November 17, 2020
Happiness Biotech Group Limited announced that the Company's experience stores started offering Coenzyme Q10 - a best-selling product from Xiamen Kingdomway Group Company.
Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific prnasia
November 11, 2020
Singapore-based Holmusk announced a collaboration with the Healthcare business sector of Merck, a leading science and technology company to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes.
Drug used to treat opioid addiction can reverse some adverse events caused by type 2 diabetes: Study expresspharma
November 04, 2020
IIT Mandi researchers find that low-dose naltrexone (LDN) can activate SIRT1, a critical protein molecule, thereby reducing inflammation and increasing insulin sensitivity of cells.
Merck Manuals Shares What Parents Need to Know About Adolescent Prediabetes prnewswire
October 30, 2020
Nearly one in five adolescents are living with prediabetes. Prediabetes is a critical warning sign in children at risk of developing type 2 diabetes.
Zydus Cadila receives tentative USFDA approval for Linagliptin Tablets expresspharma
October 30, 2020
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor to improve glycemic control in adults with Type 2 diabetes mellitus.
Zydus Cadila gets tentative US FDA approval for Dapagliflozin Tablets expresspharma
October 30, 2020
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated to improve glycemic control in adults with type 2 diabetes mellitus.
Daewoong Pharmaceutical announces Korea's first-ever SGLT2 inhibitor for diabetes treatment prnasia
September 30, 2020
Daewoong Pharmaceutical (Daewoong) (CEO Sengho Jeon) announced the result of its phase 2 clinical trial on enavogliflozin, SGLT2 inhibitor for diabetes currently in the process of development, for the first time at the ...
‘One size fits all’ medication approach doesn’t work in pregnancy University of South Australia
September 24, 2020
New research led by the University of South Australia shows that a blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk for the rest of their lives.
Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets expresspharma
September 18, 2020
They are oral diabetes medicines that help control blood sugar levels.
ReShape Announces Positive Preclinical Results for Diabetes Neuromodulation Device americanpharmaceuticalreview
September 17, 2020
ReShape Lifesciences announced preclinical research demonstrating the Company's investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™) proprietary device for the treatment of type 2 diabetes mellitus (T2DM) was well-tolerated and met the study ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page